Re: ZHCLF trades on the OTC
in response to
by
posted on
Jan 20, 2021 10:10AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Wondering how would the ongoing OTC trading affect a Zenith IPO?
Koo